Lennox-Gastaut Syndrome Drug Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Lennox-Gastaut Syndrome Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.2% during the forecast period.

    This report presents the market size and development trends by detailing the Lennox-Gastaut Syndrome Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Lennox-Gastaut Syndrome Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Lennox-Gastaut Syndrome Drug industry and will help you to build a panoramic view of the industrial development.

    Lennox-Gastaut Syndrome Drug Market, By Type:

    • Perampanel

    • Cannabidiol

    • NRP-2945

    • Fenfluramine Hydrochloride

    • Others

    Lennox-Gastaut Syndrome Drug Market, By Application:

    • Hospital

    • Clinic

    • Household

    Some of the leading players are as follows:

    • GW Pharmaceuticals Plc

    • INSYS Therapeutics Inc

    • Zogenix Inc

    • Eisai Co Ltd

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Lennox-Gastaut Syndrome Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 Perampanel

      • 1.3.2 Cannabidiol

      • 1.3.3 NRP-2945

      • 1.3.4 Fenfluramine Hydrochloride

      • 1.3.5 Others

    • 1.4 Market Segment by Application

      • 1.4.1 Hospital

      • 1.4.2 Clinic

      • 1.4.3 Household

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Lennox-Gastaut Syndrome Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Lennox-Gastaut Syndrome Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Lennox-Gastaut Syndrome Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Lennox-Gastaut Syndrome Drug Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Lennox-Gastaut Syndrome Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Lennox-Gastaut Syndrome Drug by Major Types

      • 3.4.1 Perampanel

      • 3.4.2 Cannabidiol

      • 3.4.3 NRP-2945

      • 3.4.4 Fenfluramine Hydrochloride

      • 3.4.5 Others

    4 Segmentation of Lennox-Gastaut Syndrome Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Lennox-Gastaut Syndrome Drug by Major End-Users

      • 4.4.1 Hospital

      • 4.4.2 Clinic

      • 4.4.3 Household

    5 Market Analysis by Major Regions

    • 5.1 Global Lennox-Gastaut Syndrome Drug Production Analysis by Top Regions

    • 5.2 Global Lennox-Gastaut Syndrome Drug Consumption Analysis by Top Regions

    • 5.3 Global Lennox-Gastaut Syndrome Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Lennox-Gastaut Syndrome Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Lennox-Gastaut Syndrome Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Lennox-Gastaut Syndrome Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Lennox-Gastaut Syndrome Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of Lennox-Gastaut Syndrome Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in Lennox-Gastaut Syndrome Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Lennox-Gastaut Syndrome Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Lennox-Gastaut Syndrome Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Lennox-Gastaut Syndrome Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Lennox-Gastaut Syndrome Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Lennox-Gastaut Syndrome Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Lennox-Gastaut Syndrome Drug Landscape Analysis

    • 7.1 North America Lennox-Gastaut Syndrome Drug Landscape Analysis by Top Countries

      • 7.1.1 United States Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 7.1.2 Canada Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 7.1.3 Mexico Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

    8. Europe Lennox-Gastaut Syndrome Drug Landscape Analysis

    • 8.1 Europe Lennox-Gastaut Syndrome Drug Landscape Analysis by Major Types

    • 8.2 Europe Lennox-Gastaut Syndrome Drug Landscape Analysis by Major End-Users

    • 8.3 Europe Lennox-Gastaut Syndrome Drug Landscape Analysis by Top Countries

      • 8.3.1 Germany Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.2 UK Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.3 France Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.4 Italy Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.5 Spain Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.6 Belgium Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.7 Poland Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.8 Russia Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.9 Turkey Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.10 Netherlands Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.11 Portugal Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.12 Denmark Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.13 Finland Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.14 Iceland Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.15 Norway Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 8.3.16 Sweden Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Lennox-Gastaut Syndrome Drug Landscape Analysis

    • 9.1 Asia Pacific Lennox-Gastaut Syndrome Drug Landscape Analysis by Top Countries

      • 9.1.1 China Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 9.1.2 Japan Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 9.1.4 India Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 9.1.5 ASEAN Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 9.1.6 South Korea Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

    10 LAMEA Lennox-Gastaut Syndrome Drug Landscape Analysis

    • 10.1 LAMEA Lennox-Gastaut Syndrome Drug Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 10.1.2 Brazil Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 10.1.3 North Africa Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 10.1.4 South Africa Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

      • 10.1.5 Argentina Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 GW Pharmaceuticals Plc

      • 11.1.1 GW Pharmaceuticals Plc Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 INSYS Therapeutics Inc

      • 11.2.1 INSYS Therapeutics Inc Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Zogenix Inc

      • 11.3.1 Zogenix Inc Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Eisai Co Ltd

      • 11.4.1 Eisai Co Ltd Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 94 Figures and 144 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Perampanel

    • Figure Market Size and Growth Rate of Cannabidiol

    • Figure Market Size and Growth Rate of NRP-2945

    • Figure Market Size and Growth Rate of Fenfluramine Hydrochloride

    • Figure Market Size and Growth Rate of Others

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Household

    • Figure North America Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure United States Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure China Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure India Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Lennox-Gastaut Syndrome Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Lennox-Gastaut Syndrome Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Lennox-Gastaut Syndrome Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Lennox-Gastaut Syndrome Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Lennox-Gastaut Syndrome Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Perampanel

    • Figure Market Size and Growth Rate of Cannabidiol

    • Figure Market Size and Growth Rate of NRP-2945

    • Figure Market Size and Growth Rate of Fenfluramine Hydrochloride

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Lennox-Gastaut Syndrome Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Lennox-Gastaut Syndrome Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Household

    • Table Global Lennox-Gastaut Syndrome Drug Production by Major Regions

    • Table Global Lennox-Gastaut Syndrome Drug Production Share by Major Regions

    • Table Global Lennox-Gastaut Syndrome Drug Consumption by Major Regions

    • Table Global Lennox-Gastaut Syndrome Drug Consumption Share by Major Regions

    • Table North America Lennox-Gastaut Syndrome Drug Production, Import, Consumption and Export Analysis

    • Table Europe Lennox-Gastaut Syndrome Drug Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Lennox-Gastaut Syndrome Drug Production, Import, Consumption and Export Analysis

    • Table LAMEA Lennox-Gastaut Syndrome Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Lennox-Gastaut Syndrome Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Lennox-Gastaut Syndrome Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Lennox-Gastaut Syndrome Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Lennox-Gastaut Syndrome Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Lennox-Gastaut Syndrome Drug Consumption by Major Countries from 2014 to 2026

    • Table North America Lennox-Gastaut Syndrome Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Lennox-Gastaut Syndrome Drug Consumption Share by Major Countries in 2014

    • Figure North America Lennox-Gastaut Syndrome Drug Consumption Share by Major Countries in 2018

    • Figure North America Lennox-Gastaut Syndrome Drug Consumption Share by Major Countries in 2026

    • Figure United States Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Lennox-Gastaut Syndrome Drug Consumption by Types from 2014 to 2026

    • Table Europe Lennox-Gastaut Syndrome Drug Consumption Share by Types from 2014 to 2026

    • Table Europe Lennox-Gastaut Syndrome Drug Consumption by End-Users from 2014 to 2026

    • Table Europe Lennox-Gastaut Syndrome Drug Consumption Share by End-Users from 2014 to 2026

    • Table Europe Lennox-Gastaut Syndrome Drug Consumption by Major Countries from 2014 to 2026

    • Table Europe Lennox-Gastaut Syndrome Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure France Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Lennox-Gastaut Syndrome Drug Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Lennox-Gastaut Syndrome Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure China Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure India Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Lennox-Gastaut Syndrome Drug Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Lennox-Gastaut Syndrome Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Lennox-Gastaut Syndrome Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GW Pharmaceuticals Plc

    • Figure Sales and Growth Rate Analysis of GW Pharmaceuticals Plc

    • Figure Revenue and Market Share Analysis of GW Pharmaceuticals Plc

    • Table Product and Service Introduction of GW Pharmaceuticals Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of INSYS Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of INSYS Therapeutics Inc

    • Figure Revenue and Market Share Analysis of INSYS Therapeutics Inc

    • Table Product and Service Introduction of INSYS Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zogenix Inc

    • Figure Sales and Growth Rate Analysis of Zogenix Inc

    • Figure Revenue and Market Share Analysis of Zogenix Inc

    • Table Product and Service Introduction of Zogenix Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai Co Ltd

    • Figure Sales and Growth Rate Analysis of Eisai Co Ltd

    • Figure Revenue and Market Share Analysis of Eisai Co Ltd

    • Table Product and Service Introduction of Eisai Co Ltd

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.